Composition

Details for Australian Patent Application No. 2006226459 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Stephenne, Jean; Hanon, Emmanuel Jules

Agent Shelston IP

Pub. Number AU-A-2006226459

PCT Pub. Number WO2006/100111

Priority 0510598.6 24.05.05 GB; 0506004.1 23.03.05 GB; 0505998.5 23.03.05 GB; 0506001.7 23.03.05 GB; 0603788.1 24.02.06 GB; 0510596.0 24.05.05 GB; 0603789.9 24.02.06 GB; 0603790.7 24.02.06 GB; 0510589.5 24.05.05 GB; 0510593.7 24.05.05 GB; 0506000.9 23.03.05 GB; 0505989.4 23.03.05 GB; 0510591.1 24.05.05 GB

Filing date 21 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100111 Priority application(s): WO2006/100111

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226460-Plants having increased yield and a method for making the same

2006226458-Novel composition